Linuo Pharmaceutical Packaging disclosed its 2026 semi-annual report. In the first half of the year, total operating revenue reached 673 million yuan, up 34.93 percent year on year. Net profit attributable to the parent company was 31.1574 million yuan, down 23.95 percent year on year. Non-GAAP net profit was 25.152 million yuan, down 13.09 percent. Net cash flow from operating activities was negative 68.2946 million yuan, compared with negative 9.6051 million yuan in the same period last year. Basic earnings per share were 0.12 yuan, and the weighted average return on equity was 1.74 percent. As of August 21, 2026, 21.52 percent of the company's shares were pledged. The largest shareholder, Linuo Investment Holding Group, pledged 53.93 million shares, accounting for 78.28 percent of its total holdings.
Shandong Linuo Technical Glass Co.Ltd.Net profit fell 23.95% year-on-year despite revenue growth, and operating cash flow turned more negative.
As largest shareholder, its pledged shares represent 78.28% of its holdings, indicating potential financial strain.
